Evidence map›Paper›PMID 32314191›Full record

ArticleInternational journal of colorectal disease2020

Effects of tumor distance from anal verge on survival outcomes for rectal NENs and lymphatic metastasis risk score for colorectal NENs.

Xiaoling Duan, Man Zhao, Shenglei Zhang, Zhibin Xu, Lili Mi, Jianfei Shi, Xiaoying Ma, Yueping Liu, Ning Li, Xiaolei Yin and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of colorectal disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Xiaoling DuanDepartment of Gastroenterology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, People's Republic of China.
Man ZhaoDepartment of Gastroenterology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, People's Republic of China.
Shenglei ZhangDepartment of Nephrology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, People's Republic of China.
Zhibin XuDepartment of Endoscope Room, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, China.
Lili MiDepartment of Gastroenterology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, People's Republic of China.
Jianfei ShiDepartment of Gastroenterology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, People's Republic of China.
Xiaoying MaDepartment of Nephrology, Cangzhou Central Hospital, Xinhua Road, Cangzhou, 061000, Hebei, China.
Yueping LiuDepartment of Pathology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, China.
Ning LiDepartment of Gastroenterology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, People's Republic of China.
Xiaolei YinDepartment of Gastroenterology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, People's Republic of China.
Xin HanDepartment of Gastroenterology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, People's Republic of China.
Guangjie HanDepartment of Gastroenterology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, People's Republic of China.
Jinfeng WangDepartment of Gastroenterology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, People's Republic of China.
Jinsheng XuDepartment of Nephrology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, People's Republic of China. xjs5766@126.com.
Fei YinDepartment of Gastroenterology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050019, Hebei, People's Republic of China. yinfei_4y@sina.com.
Hebei Medical University · CNFourth Hospital of Hebei Medical University · CNCangzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore whether the distance of rectal neuroendocrine neoplasms from the anal margin has an impact on the prognosis of patients and evaluate lymphatic metastases risk score for colorectal neuroendocrine neoplasms (NENs).

methodsClinical pathological and follow-up data of 71 patients identified as colorectal neuroendocrine neoplasms by pathology from July 2011 to July 2019 were carefully collected.

resultsAmong 71 patients with colorectal NENs, most of the tumors were rectal NENs (62 cases). A total of 26 patients were in the presence of lymph node metastasis, and 44 patients had negative lymph nodes. Patients with lesions from the anal margin > 5 cm in rectum have a better prognosis (P = 0.022). Tumor stage (P = 0.034) and grade (P = 0.001) were independent risk predictors of lymphatic metastases. We developed a lymphatic metastasis risk score for rectal NENs, and patients with the score ≥ 7.5 were more likely to develop lymph node metastases (area 0.958, 95% CI 0.903-1.000, P = 0.000) with a sensitivity of 72.2% and a specificity of 97.3%.

conclusionPatients with lesions from the anal margin > 5 cm and lymphatic metastasis risk score ≥ 7.5 should be treated actively.

Indexed as

Neuroendocrine TumorsRectal NeoplasmsHumansLymphatic MetastasisNeoplasm StagingPrognosisRetrospective StudiesRisk FactorsClinicopathologic featuresColorectal neuroendocrine neoplasmsDistance from anal vergeLymphatic metastasisPrognosis

Identifiers

PMID32314191
OpenAlexW3016752294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.